On air · 1 of 3 networks
Shilpa Biologicals Private Limited
- shilpabio.com
- 427 employees
Shilpa Biologicals Private Limited’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 40. Watch Shilpa Biologicals Private Limited with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 24 | Checked 29 Oct 2026 | See all 40 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 9 Oct 2026 | Collect them with the API → |
Shilpa Biologicals Private Limited has 24 live LinkedIn ads. We recorded no Google ads on 9 Oct 2026.
Latest ads
- LINKEDIN · ARTICLESince 8 Oct 2026
Biosimilars are moving from a question of “Do they work?” to a more important one: “What builds confidence in using them?” As clinical evidence continues to grow, healthcare professionals are gaining greater confidence in prescribing, switching and integrating biosimilars into clinical practice. From robust comparability assessments to growing real-world experience, the evolving evidence landscape is helping strengthen trust, support patient access and accelerate biosimilar adoption worldwide. Read our latest blog to explore how evidence-based confidence is shaping the future of biosimilars in clinical practice. Vishnukant Bhutada Madhav Bhutada Keshav Bhutada Shriya Khandwe Dhruv N Raval Maria Rende, PhD PV Narasimha Rao Amal Sasidharan Hari krishna Niharika Garagad Puspadhwaja Mall, Ph. D, MBA (IIMK) Rakesh Kumawat Dr. Kiran Avadhani M Pharm, Ph D. Balaji Sunkara prasad kanitkar Ravindran C. Aravinda Narayana Andrew George Ayda Onat Orallar Irfanulla Mirza B. SHILPA MEDICARE LTD #Biosimilars #HealthcareProfessionals #Biologics #PatientAccess #PharmaInnovation #ClinicalPractice
- LINKEDIN · ARTICLESince 8 Oct 2026
In biosimilar manufacturing, quality is not something tested at the end - it is built into every stage of the process. Good Manufacturing Practices (GMP) play a critical role in ensuring consistency, safety, and efficacy while enabling innovation across biosimilar development. Read our latest blog to explore how robust manufacturing practices are shaping the future of high-quality biologics. Vishnukant Bhutada Madhav Bhutada keshav Bhutada Sridevi Khambhampaty PV Narasimha Rao Amal Sasidharan Hari krishna Niharika Garagad Puspadhwaja Mall, Ph. D, MBA (IIMK) Rakesh Kumawat Dr. Kiran Avadhani M Pharm, Ph D. Balaji Sunkara prasad kanitkar Ravindran C. Aravinda Narayana Shriya Khandwe Andrew George Ayda Onat Orallar Irfanulla Mirza B. SHILPA MEDICARE LTD Dhruv N Raval Maria Rende, PhD #ShilpaBiologicals #Biosimilars #Biologics #GMP #Biotechnology #LifeSciences #HealthcareInnovation
- LINKEDIN · VIDEOSince 25 Sept 2026
Are you looking for a reliable CDMO partner for your complex biologics manufacturing? The right partner can make the difference between development and successful scale-up. Shilpa Biologicals brings together research, process development and manufacturing capabilities across biosimilars, ADCs, recombinant human albumin and complex biologics. From early development and scale-up to commercial manufacturing and fill-finish, we help biopharmaceutical companies move projects forward with integrated capabilities under one partner. Connect with us to explore your biologics development and manufacturing requirements. Vishnukant Bhutada Madhav Bhutada Keshav Bhutada Dr. Uday Harle Shriya Khandwe Dhruv N Raval Ayda Onat Orallar Andrew George Irfanulla Mirza PV Narasimha Rao Amal Sasidharan Hari krishna SHILPA MEDICARE LTD Maria Rende, PhD Puspadhwaja Mall, Ph. D, MBA (IIMK) Rakesh Kumawat Balaji Sunkara Niharika Garagad Dr. Kiran Avadhani M Pharm, prasad kanitkar Ravindran C. Aravinda Narayana Diksha Gupta #ShilpaBiologicals #BiologicsCDMO #BiologicsDevelopment #BiologicsManufacturing #Biosimilars #ADC #ProcessDevelopment #ScaleUp #CommercialManufacturing #Biopharma #PharmaInnovation #FillFinish
- LINKEDIN · VIDEOSince 25 Sept 2026
As the demand for biologics continues to grow, healthcare systems worldwide face a critical challenge: improving access while maintaining quality and affordability. Biosimilars are helping bridge this gap. Backed by robust science, rigorous regulatory pathways, and proven clinical performance, they are expanding patient access to advanced therapies while supporting more sustainable healthcare systems. With growing global acceptance and approvals, biosimilars are playing an increasingly important role in shaping the future of healthcare. At Shilpa Biologicals, we are committed to advancing this transformation through world-class biosimilar development and manufacturing capabilities. Vishnukant Bhutada Madhav Bhutada Keshav Bhutada Shriya Khandwe Dhruv N Raval Maria Rende, PhD PV Narasimha Rao Amal Sasidharan Hari krishna Niharika Garagad Puspadhwaja Mall, Ph. D, MBA (IIMK) Rakesh Kumawat Dr. Kiran Avadhani M Pharm, Ph D. Balaji Sunkara prasad kanitkar Ravindran C. Aravinda Narayana Andrew George Ayda Onat Orallar Irfanulla Mirza B. SHILPA MEDICARE LTD #ShilpaBiologicals #Biosimilars #Biologics #HealthcareInnovation #PatientAccess #AffordableHealthcare #Biopharmaceuticals #LifeSciences #Biotechnology #GlobalHealthcare #BiologicsManufacturing #HealthcareTransformatio
- LINKEDIN · IMAGESince 23 Sept 2026
Accelerate Biosimilar Development with an Integrated Development & Manufacturing Partner From early development to commercial manufacturing, Shilpa Biologicals offers integrated mammalian and microbial platforms designed to support complex biologics programs at every stage. With expert scientific teams, scalable process capabilities, state-of-the-art cGMP facilities, quality systems, and flexible manufacturing solutions, we help biopharma companies advance biosimilar programs with greater efficiency and confidence. Our capabilities include: • Cell line & upstream process development • Harvest, clarification & downstream processing • Analytical & quality support • Drug substance manufacturing • Formulation & drug product development • Technology transfer, scale-up & commercial manufacturing Looking for a reliable partner for your next biosimilar program? Discuss your biosimilar program with Shilpa Biologicals. #Biosimilars #Biologics #CDMO #Biopharma #DrugDevelopment #Biomanufacturing #PharmaceuticalManufacturing #BiosimilarDevelopment #BiologicsManufacturing #CMC
- LINKEDIN · IMAGESince 17 Apr 2026
At Shilpa Biologicals, we empower global pharmaceutical companies with our integrated quality control capabilities that ensure agility, precision, and compliance at every stage of biologics manufacturing. Our quality control laboratory verticals span across Virology, Wet Chemistry, Microbiology, Bioassay, Mycoplasma Testing, Analytical Sciences, and Molecular Biology, supported by high-end instrumentation and globally aligned methodologies. From ensuring product safety and purity to validating biological activity, our comprehensive approach enables confident, compliant, and timely market entry for complex biologics. Madhav Bhutada Sridevi Khambhampaty Shriya Khandwe Andrew George Ayda Onat Orallar keshav Bhutada Vishnukant Bhutada Irfanulla Mirza B. SHILPA MEDICARE LTD Dhruv N Raval Maria Rende, PhD Puspadhwaja Mall, Ph. D, MBA (IIMK) Rakesh Kumawat Balaji Sunkara #ShilpaBiologicals #Biologics #QualityControl #Biopharma #GlobalPharma #AnalyticalTesting #Microbiology #Bioassay #MolecularBiology #RegulatoryCompliance #LifeSciences #CDMO
6 of 40 adsSign up to see every Shilpa Biologicals Private Limited ad, filter by format and date, and get alerts on new ones.
See all 40 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.